1. OPKO’s Emerging Markets
OPKO Chile – Pharma Genexx, S.A.
Acquired October 2009
Also acquired ALD Distribution, Ltd. in April 2012
Rapidly growing sales from > 100 products
Revenues:
2010: $18.0 MM
2011: $21.5 MM
Expected 2012: $26-$30 MM
OPKO Mexico – Pharmacos Exakta S.A. de C.V.
Acquired February 2010
25 products across a range of therapeutic indications
Primarily branded ophthalmics
Expanding proprietary focus
2010: $3.8 MM
2011: $6.4 MM
OPKO FineTech – FineTech Pharmaceuticals, Ltd.
Acquired December 2011
Develops and produces high value, high potency APIs (active pharmaceutical ingredients)
FDA registered, state-of-the-art facility in Nesher, Israel
Revenue:
1Q 2012: $1.6 MM